[PDF] Top 20 Moderated Posters 1: Oncology Prostate

... potential prostate cancer causal ...normal prostate inflammation on carcinogen- ...normal prostate epithelial cells on prostate ...sive prostate cancers (Gleason ≥8 or pathological ... See full document

... Methods: This was a single centre retrospective study of men with advanced prostate cancer followed in a clinical research centre at Queen’s University. Patients were included if they had received androgen ... See full document

... Results: Knockdown of HIF-1α in DU145 prostate cancer cells abro- gated the hypoxia-induced down-regulation of surface MICA levels (P < 0.001(ANOVA) as well as hypoxia-induced resistance to NK cell-mediated ... See full document

... Introduction and Objectives: Phenotypic differentiation of patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) may improve under- standing of the pathogenesis and heterogeneity of the condition as well as ... See full document

... Materials and Methods: Patients who presented with advanced RCC were offered enrolment in a single-centre, IRB- approved trial with 12 weeks of temsirolimus before laparoscopic radical nephrectomy. Biopsy tissue was ... See full document

... Methods: This multicentre cohort consisted of 331 men diagnosed with unilateral PCa who underwent RARP. Localization and occurrence of posi- tive cores from biopsy, cEPE, cPSM and SVI was noted (Table 1). cEPE+ ... See full document

... Background: Recently, hospital antibiograms have reported quinolone- resistant E. coli in 25% of cases and the reported increased rate of infec- tious complications following transrectal needle prostate biopsy ... See full document

... prostatectomy. 1 man had a prior male sling ...at 1-month (preop: 35.6 and 1 month: ...our 1 month data supported its role in the treatment of male ... See full document

... Results: 24 men, with a mean age of 70.6 years (range 53-86), success- fully underwent in office laser prostatectomy. The mean prostate volume was 42.6 grams (range 20-78 grams) and mean PSA was 1.8±1.2 ng/ mL. ... See full document

... Results: A total of 110 urologists responded (17% response rate); 51% were <45 years of age, 18% were >64 years old. Approximately half (45%) were academic urologists, 21% had completed an oncology fel- ... See full document

... Results: The cell cycle progression signature was a highly significant predic- tor of outcome in all five studies. In conservatively managed patients, the CCP score was the dominant variable for predicting death from ... See full document

... Background: Prostate mpMRI and its lesion suspicion (via Likert, PIRADs, etc) has emerged as an excellent predictor of cancer ...with prostate mpMRI and targeted biopsy to identify improved predictors of ... See full document

... with prostate cancer and scheduled for radical prostatectomy under- went real time elastography and contrast enhanced MRI before radical prostatectomy at least 6 weeks after prostate biopsy by independent ... See full document

... Methods: Using Surveillance, Epidemiology, End Results data linked to Medicare records, we identified patients with high risk, bladder cancer, who were diagnosed from 2004-2005 with follow-up through 2007. High risk ... See full document

... Method: This single centre, retrospective study included 86 prostate can- cer (PCa) patients treated with RP who had a rapidly rising PSA recur- rence. Patients were elected to be treated with daily bicalutamide ... See full document

... Introduction and Objective: Increasing evidence suggests that radical nephrectomy (RN) is associated with an increased incidence of chronic kidney disease (CKD) compared to partial nephrectomy (PN) following the ... See full document

... 1 g or placebo po QD, plus prednisone (P) 5 mg po BID. Radiographic progression-free survival (rPFS) and overall survival (OS) were co-primary endpoints. Primary and secondary endpoints were compared between ... See full document

... Methods: We analyzed our institutional review board approved pro- spectively collected database of consecutive patients who underwent primary HIFU (Ablatherm, EDAP, Lyon) for prostate cancer. Patients were ... See full document

... for prostate can- cer detection between years 1988 and 2005 within the Surveillance, Epidemiology, and End Results (SEER) Medicare-linked database were ...from 1 to ... See full document

... Results: 3 cases were open converted (2 failure to progress, 1 hypercar- bia). PSM was found in 19 (34%). At univariable analysis, no association was observed between PSM and age, BMI, PSA, number positive cores, ... See full document